Monday, 27 May 2024

Sartorius Stedim ( Single-Use Modules Expedite Total Solutions )

20 June 2019 | Analysis

Sponsored By : Sartorius Stedim

 Single-Use Modules Expedite Total Solutions 


As the biopharmaceutical industry continues to grow at a rapid pace, companies are realizing that they may need to transform their biomanufac-turing networks to respond to changing market dynamics and anticipate customer requirements. A major factor behind the growth of the biopharma-ceutical industry has been the huge and continued success of the monoclonal antibodies segment. Within the industry, however, companies have started to diversify their pipelines, developing products such as antibody-drug conju-gates, non-antibody recombinant proteins, gene therapies, and autologous and allogenic cell therapies.


Click here to access white paper

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account